Spontaneous regression of diffuse large B-cell lymphoma in the small intestine with multiple lymphadenopathy

Diffuse large B cell lymphoma (DLBCL) is classified as an aggressive lymphoma due to its poor prognosis regardless of the treatment. Almost all cases of DLBCL are treated using rituximab-combination chemotherapy, but spontaneous regression without any therapeutic modalities may rarely occur. A 35-ye...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yasuhiro, Ishihara, Misa, Miyoshi, Hiroaki, Hashimoto, Akiko, Shinzato, Isaku, Ohshima, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JSLRT 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528139/
https://www.ncbi.nlm.nih.gov/pubmed/30918140
http://dx.doi.org/10.3960/jslrt.18020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528139/
https://www.ncbi.nlm.nih.gov/pubmed/30918140
http://dx.doi.org/10.3960/jslrt.18020

Ejemplares similares